The Genomic Atlas of Breast Cancer — the non-coding theme

Update News

  • GABC update 2020.06.15
  • GABC update 2019.03.20
  • GABC online 2018.08.09
  • Data collection 2018.04.09

About Us

  • Steven Xi Chen:
    steven.chen@miami.edu
  • Yunpeng Zhang:
    YXZ1418@med.miami.edu
  • Peng Wang:
    wpgqy@163.com
  • Shangwei Ning:
    ningsw@ems.hrbmu.edu.cn
  • Xia Li:
    lixia@hrbmu.edu.cn

Detail


Chr NA
start NA
end NA
lncRNA name ANAC
entrez id NA
hgnc id NA
ensg id NA
refseq id NA
methods qPCR, Western blot, Luciferase reporter assay etc.
regulated down-regulated
function description We find that lncRNA ANCR participates in TGF-B1-induced EMT. By our ChIP and Real-time PCR assays, we reveal that TGF-B1 down-regulates ANCR expression by increasing HDAC3 enrichment at ANCR promoter region, which decreases both H3 and H4 acetylation of ANCR promoter. In addition, by western blot and transwell assays, we indicate that ectopic expression of ANCR partly attenuates the TGF-B1-induced EMT. Downstream, ANCR inhibits breast cancer cell migration and breast cancer metastasis by decreasing RUNX2 expression in vitro and in vivo. Thus, our study identifies ANCR, as a new TGF-B downstream molecular, is essential for TGF-B1-induced EMT by decreasing RUNX2 expression. These results implicate that ANCR might become a prognostic biomarker and an anti-metastasis therapy target for breast cancer. These results demonstrate that ANCR is down-regulated during the TGF-B1-induced EMT in MCF10A cells.
pubmed id 28978036
year 2017
title LncRNA ANCR down-regulation promotes TGF-B-induced EMT and metastasis in breast cancer.
drug X
circulating X
survival X

CopyRight © University of Miami, USA; Harbin Medical University, China